2 reports

  • H. Lundbeck A/S - Research and Development Overview

R& D Progress Research and Development Brief H.

  • Research And Development
  • Therapy
  • United States
  • Company Operations
  • H. Lundbeck A/S

One patient who received only one ## mg/ kg and one ## mg/ kg dose (instead of ## doses at ## mg/ kg) due to an unrelated SAE was excluded from this analysis, and restarted treatment at week ##.

  • Pharmaceutical
  • Research And Development
  • United States
  • Company Operations
  • Alexion Pharmaceuticals, Inc.